Walleye Trading’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-6,800
Closed -$662K 4853
2020
Q2
$662K Sell
6,800
-6,400
-48% -$596K ﹤0.01% 2023
2020
Q1
$1.1M Buy
13,200
+1,500
+13% +$146K 0.01% 1240
2019
Q4
$1.3M Buy
11,700
+1,600
+16% +$165K 0.01% 1571
2019
Q3
$1M Sell
10,100
-400
-4% -$39.7K 0.01% 1601
2019
Q2
$1.04M Buy
10,500
+1,800
+21% +$172K 0.01% 1563
2019
Q1
$960K Buy
8,700
+7,500
+625% +$784K 0.01% 1710
2018
Q4
$110K Sell
1,200
-1,800
-60% -$182K ﹤0.01% 3838
2018
Q3
$331K Buy
3,000
+2,000
+200% +$208K ﹤0.01% 3316
2018
Q2
$93K Sell
1,000
-1,200
-55% -$103K ﹤0.01% 4078
2018
Q1
$183K Buy
+2,200
New +$195K ﹤0.01% 3562

Other funds holding PRAH

Walleye Trading's PRAH Position: Q3 2020 in Review

Walleye Trading sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2020, closing a stake of 436 shares — an estimated $42K sold.

Walleye Trading first reported a position in PRAH in Q4 2015 and held it in 12 quarters. The position peaked at $639K in Q4 2016. 281 funds tracked by Wall St. Rank hold PRAH as of Q3 2020.

  • Walleye Trading reported no remaining PRA Health Sciences, Inc. position as of Q3 2020 after selling out during the quarter.
  • Walleye Trading sold 436 PRA Health Sciences, Inc. shares in Q3 2020, an estimated $42K.
  • Walleye Trading first reported a position in PRA Health Sciences, Inc. in Q4 2015 and held it in 12 quarters.
  • Walleye Trading's PRA Health Sciences, Inc. position peaked at $639K in Q4 2016.
  • 281 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2020.

Based on Walleye Trading's 13F filing for Q3 2020, filed 16 Nov 2020.